Large-scale testing (Phase 3)Study completedNCT04929249
What this trial is testing
Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE)
Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 450